| Literature DB >> 32287295 |
Flavia Mello Viegas1, Carolina Pantuzza Ramos1, Rafael Gariglio Clark Xavier1, Emily Oliveira Lopes1, Carlos Augusto Oliveira Júnior1, Renata Marques Bagno1, Amanda Nadia Diniz1, Francisco Carlos Faria Lobato1, Rodrigo Otávio Silveira Silva1.
Abstract
The present study aimed to explore the motivations of Brazilian dog owners and their knowledge about the risks related to raw meat-based diets (RMBD) as well as to evaluate important enteropathogens such as Salmonella spp., C. perfringens, and C. difficile, in feces of dogs fed different diets. The majority of the pet owners (69.3%) reported to have chosen this diet for their dogs, considering it to be more "natural". A large number of owners declared that RMBD do not pose health risks for their animals (87.9%) or humans (98.8%), even though almost one third of the respondents (34.8%) declared having at least one individual at high risk of infection in contact with RMBD-fed dogs. Stool samples from 46 RMBD-fed dogs and 192 dogs fed commercial dry feed were collected. The present study revealed that dogs fed raw meat diets were almost 30 times more likely to be positive for Salmonella spp. than dogs on a conventional diet. Some of the serovars detected were commonly associated with human salmonellosis, such as S. Typhimurium and S. Saintpaul, and were multidrug resistant. RMBD-fed dogs were more likely to be positive for C. perfringens type A (p = 0.008) and one C. perfringens type F was isolated from these animals. Two toxigenic strains (4.3%) of C. difficile were isolated only from raw meat-fed dogs, all of which were under antibiotic therapy. These toxigenic C. difficile isolates were classified as RT106/ST54 and RT600/ST149, previously associated with infection in dogs and humans. The present work revealed that the owners have a tendency to ignore or are unaware of the risks associated with raw meat diets for dogs. Also, the higher fecal shedding of important enteropathogens in dogs fed RMBD suggests that this diet poses a risk for the animals and the people in contact with them.Entities:
Year: 2020 PMID: 32287295 PMCID: PMC7156072 DOI: 10.1371/journal.pone.0231275
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Main reasons associated with adoption of RMBD for dogs in Brazil (n = 166) (a), individuals in increased risk of Salmonella spp. infection in contact with RMBD-fed dogs (n = 55) (b), perception of risks for humans and animals associated with RMBD for dogs (n = 166) (c).
Frequency of isolation of Salmonella spp., Clostridium perfringens and Clostridioides difficile from dogs fed commercial dry feed or “Raw meat-based diet” (n = 238).
| Dogs diet | ||||||
|---|---|---|---|---|---|---|
| Type A | Type F | Isolation | Toxigenic (A+B+CDT-) | RT/ST | ||
| 1 (0.5%) b | 92 (47.9%)b | 0 (0%) | 4 (2.1%) | 0 (0%) | - | |
| 7 (15.2%) a | 32 (69.6%)a | 1 (2.2%) | 2 (4.3%) | 2 (4.3%) | 106/52 600/149 | |
| 8 (3.4%) | 124 (52.1%) | 1 (0.4%) | 6 (2.5%) | 2 (0.8%) | - | |
Different lower-case letters indicate a significant difference (p < 0.01)
1Stool sample negative for enterotoxin (CPE) in a commercial EIA test and negative for NetF-encoding gene by PCR
2One stool sample were positive for A/B toxins in a commercial EIA test.
Serotypes of Salmonella enterica not susceptible for different antimicrobial agents isolated from dogs feed commercial dry feed diet (n = 1) and raw-meat based diet (n = 7).
| Serotype | No. of isolates | Dog diet | Antimicrobial |
|---|---|---|---|
| 2 | Raw meat based | OXT, STX, MTZ, STR, ENR | |
| Raw meat based | OXT, MTZ, STR | ||
| 3 | Raw meat based | OXT, STX, MTZ | |
| Raw meat based | Susceptible to all tested antimicrobials | ||
| Commercial dry feed | MTZ, STR | ||
| 1 | Raw meat based | OXT, MTZ | |
| 1 | Raw meat based | AMC, OXT, STX, MTZ, STR | |
| 1 | Raw meat based | STX, MTZ |
1 Disc diffusion method according to Clinical and Laboratory Standards Institute (CLSI).
AMC, amoxicillin/clavulanic acid; ENR, enrofloxacin; MTZ, metronidazole; OXT, oxytetracycline; STR, streptomycin; STX, trimethoprim/sulfamethoxazole.